Recent studies indicate that these neurotransmitters have tumor-promoting features; thus, this might help to further explain the unfavorable prognosis of IDH1-WT compared with IDH1-mut diffuse glioma (17–20). This evidence concerns the gene IDH1 and neoplasm.